Health Condition 1: J329- Chronic sinusitis, unspecified
Conditions
Interventions
Intervention1: jadwar (Delphinium denudatum): The intervention group will receive Jadwar (Delphinium denudatum) in capsule form at a dose of 500 mg, administered orally twice daily with lukewarm water
Sponsors
Jamia Hamdard University
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged between 18 and 60 years of either gender. Clinically diagnosed cases of chronic sinusitis confirmed by nasal endoscopy and/or radiological imaging. Patients experiencing symptoms such as nasal congestion, facial pain or pressure, headache, or post-nasal drip persisting for at least 4 weeks. Patients who are willing to provide written informed consent and comply with the study protocol and follow-up schedule.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. Patients with a history of recent nasal or sinus surgery. Patients suffering from any major systemic disorder. Patients with immunocompromised conditions such as HIV or tuberculosis. Patients who have used corticosteroids, antibiotics, or other treatments for sinusitis within the past four weeks. Patients with nasal polyps or significant sinonasal structural abnormalities (e.g., markedly deviated nasal septum).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total SNOT-22 (Sino-Nasal Outcome Test-22) score in patients with chronic sinusitis treated with Jadwar.Timepoint: Baseline (Day 0) and Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in quality of life assessed by SF-12 questionnaire.Timepoint: Baseline (Day 0) and Day 30 | — |
Countries
India
Contacts
Public ContactDr Shoaib Khan
Jamia Hamdard
Outcome results
None listed